Oxford Nanopore Technologies plc (LSE: ONT), the London-listed developer of nanopore-based molecular sensing technology, has announced its participation in four investor conferences across the United States and United Kingdom throughout November 2026. The events will feature appearances from both Chief Executive Officer Francis Van Parys and Chief Financial Officer Nick Keher. Investors will have the opportunity to follow select sessions via webcast through Oxford Nanopore's Investor Relations website, with replays available for at least 30 days after each event.

Key Points

  • Oxford Nanopore Technologies plc (LSE: ONT) is a nanopore-based molecular sensing technology company operating in more than 125 countries.
  • The company will participate in four investor conferences during November 2026, spanning New York, London, and Windsor.
  • Sessions span 10 November to 30 November 2026, covering fireside chats, a formal presentation, and a Q&A session.
  • Investors should watch the Jefferies Global Healthcare Conference on 17 November, where CEO Francis Van Parys will deliver a full presentation followed by a Q&A session alongside CFO Nick Keher.

CFO Nick Keher to Represent ONT at Stifel and Canaccord Forums in New York

Oxford Nanopore's conference schedule opens in New York with two back-to-back engagements. On Tuesday, 10 November, Chief Financial Officer Nick Keher will participate in an analyst-led fireside chat at the Stifel Healthcare Conference at 1:20pm EST (6:20pm GMT). The following day, 11 November, Keher will appear at the Canaccord Medtech, Diagnostics and Digital Health & Services Forum at 11:30am EST (4:30pm GMT). Both sessions will be accompanied by investor meetings, and webcasts of both fireside chats will be accessible via Oxford Nanopore's Investor Relations website and available for replay for at least 30 days.

CEO Francis Van Parys to Present at Jefferies Global Healthcare Conference in London on 17 November

The most structured engagement of the month takes place at the Jefferies Global Healthcare Conference in London on Tuesday, 17 November. Chief Executive Officer Francis Van Parys will deliver a formal presentation at 11:00am GMT (6:00am EST), followed by a Q&A session joined by CFO Nick Keher. This format offers a broader platform than a fireside chat, allowing management to present Oxford Nanopore's strategic narrative directly to an international healthcare investment audience. A webcast of the session will be made available through the company's Investor Relations website for a minimum replay window of 30 days.

Both Senior Executives to Appear Together at Berenberg European Conference in Windsor

Closing out the month, Oxford Nanopore will participate in the Berenberg European Conference in Windsor on Monday, 30 November. Both Francis Van Parys and Nick Keher will jointly appear in an analyst-led fireside chat at 1:15pm GMT, alongside associated investor meetings. The announcement does not indicate that this session will be webcast. Oxford Nanopore's technology is currently deployed in more than 125 countries for real-time analysis of DNA and RNA, with applications spanning healthcare, food, and agriculture — sectors that are likely to feature in discussions with institutional investors at these events.